Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy
L. Bartalini, Margherita Rimini, Masafumi Ikeda, Oluseyi Abidoye et autres
0 citationsCancers
Elisabetta Fenocchio
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
80Publications signalées
2400Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Colorectal Cancer Treatments and StudiesCancer Genomics and DiagnosticsLung Cancer Treatments and MutationsGenetic factors in colorectal cancerCholangiocarcinoma and Gallbladder Cancer Studies
Publications récentes
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ ‐1 Study Eligibility: A Large Global Analysis in a Real‐World Setting
Federica Lo Prinzi, Margherita Rimini, Masafumi Ikeda, Oluseyi Abidoye et autres
0 citationsInternational Journal of Cancer
Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real‐World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab
Margherita Rimini, Angela Lamarca, Masafumi Ikeda, Oluseyi Abidoye et autres
0 citationsInternational Journal of Cancer
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis
Silvia Camera, A. Vogel, M. Rimini, Masafumi Ikeda et autres
0 citationsESMO Open
Propensity score–matched analysis of trifluridine-tipiracil plus bevacizumab (FTD/TPI+Bev) vs anti-EGFR re-treatment in pretreated metastatic colorectal cancer (mCRC).
G. Trovato, Daniele Rossini, Paolo Ciracì, Chiara Cavalli et autres
0 citationsJournal of Clinical Oncology
Post‐surgery level of circulating DNA in stage III colon cancer patients: Impact on the reliability of minimal residual disease detection
Andrei Kudriavtsev, S. Daoud, Catalina Isabel Cofre Muñoz, Alexia Mirandola et autres
0 citationsInternational Journal of Cancer
Data from The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial
Andrea Botticelli, Chiara Cremolini, Simone Scagnoli, Mauro Biffoni et autres
0 citations
Supplementary Figure S3 from The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial
Andrea Botticelli, Chiara Cremolini, Simone Scagnoli, Mauro Biffoni et autres
0 citations
Supplementary Figure S6 from The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial
Andrea Botticelli, Chiara Cremolini, Simone Scagnoli, Mauro Biffoni et autres
0 citations
Supplementary Figure S1 from The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial
Andrea Botticelli, Chiara Cremolini, Simone Scagnoli, Mauro Biffoni et autres
0 citations
Supplementary Figure S2 from The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial
Andrea Botticelli, Chiara Cremolini, Simone Scagnoli, Mauro Biffoni et autres
0 citations
Supplementary Figure S7 from The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial
Andrea Botticelli, Chiara Cremolini, Simone Scagnoli, Mauro Biffoni et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.